IDEAS home Printed from https://ideas.repec.org/a/aph/ajpbhl/19988881239-1242_5.html
   My bibliography  Save this article

Cost-effectiveness of a community-level HIV risk reduction intervention

Author

Listed:
  • Pinkerton, S.D.
  • Holtgrave, D.R.
  • DiFranceisco, W.J.
  • Stevenson, L.Y.
  • Kelly, J.A.

Abstract

Objectives. The authors evaluated the cost-effectiveness of a community- level HIV prevention intervention that used peer leaders to endorse risk reduction among gay men. Methods. A mathematical model of HIV transmission was used to translate reported changes in sexual behavior into an estimate of the number of HIV infections averted. Results. The intervention cost $17 150, or about $65 000 per infection averted, and was therefore cost-saving, even under very conservative modeling assumptions. Conclusions. For this intervention, the cost of HIV prevention was more than offset by savings in averted future medical care costs. Community-level interventions to prevent HIV transmission that use existing social networks can be highly cost- effective.

Suggested Citation

  • Pinkerton, S.D. & Holtgrave, D.R. & DiFranceisco, W.J. & Stevenson, L.Y. & Kelly, J.A., 1998. "Cost-effectiveness of a community-level HIV risk reduction intervention," American Journal of Public Health, American Public Health Association, vol. 88(8), pages 1239-1242.
    • Handle: RePEc:aph:ajpbhl:1998:88:8:1239-1242_5
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a search for a similarly titled item that would be available.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Stephanie Earnshaw & Katherine Hicks & Anke Richter & Amanda Honeycutt, 2007. "A linear programming model for allocating HIV prevention funds with state agencies: a pilot study," Health Care Management Science, Springer, vol. 10(3), pages 239-252, September.
    2. Kathleen J. Sikkema, 2005. "HIV Prevention among Women in Low-Income Housing Developments: Issues and Intervention Outcomes in a Place-Based Randomized Controlled Trial," The ANNALS of the American Academy of Political and Social Science, , vol. 599(1), pages 52-70, May.
    3. Margaret Brandeau & Gregory Zaric, 2009. "Optimal investment in HIV prevention programs: more is not always better," Health Care Management Science, Springer, vol. 12(1), pages 27-37, March.
    4. Juan Manuel Cabasés Hita & Eduardo Sánchez Iriso, 2002. "Costs and Effectiveness of a syringe distribution and needle exchange programme for HIV prevention in a regional setting," Documentos de Trabajo - Lan Gaiak Departamento de Economía - Universidad Pública de Navarra 0204, Departamento de Economía - Universidad Pública de Navarra.
    5. Melchior, Lisa A. & Huba, G. J. & Brown, Vivian B. & Slaughter, Ruth, 1999. "Evaluation of the effects of outreach to women with multiple vulnerabilities on entry into substance abuse treatment," Evaluation and Program Planning, Elsevier, vol. 22(3), pages 269-277, August.
    6. David R. Holtgrave, 2004. "HIV Prevention, Cost-Utility Analysis, and Race/Ethnicity: Methodological Considerations and Recommendations," Medical Decision Making, , vol. 24(2), pages 181-191, March.
    7. Ana P. Johnson-Masotti & Purushottam W. Laud & Raymond G. Hoffmann & Matthew J. Hayat & Steven D. Pinkerton, 2001. "Probabilistic Cost-Effectiveness Analysis of HIV Prevention," Evaluation Review, , vol. 25(4), pages 474-502, August.
    8. Steven D. Pinkerton & Harrell W. Chesson & David R. Holtgrave & William Kassler & Peter M. Layde, 2000. "When is an HIV Infection Prevented and when is it Merely Delayed?," Evaluation Review, , vol. 24(3), pages 251-271, June.
    9. Juan Cabasés & Eduardo Sánchez, 2003. "Costs and effectiveness of a syringe distribution and needle exchange program for HIV prevention in a regional setting," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 4(3), pages 203-208, September.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:aph:ajpbhl:1998:88:8:1239-1242_5. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Christopher F Baum (email available below). General contact details of provider: https://www.apha.org .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.